Hogan, S. E., Debus, E. S., Nehler, M. R., Patel, M. R., Anand, S. S., Muehlhofer, E., … Bonaca, M. P. (2024). Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD. Circulation, 149(8), 635–637. https://doi.org/10.1161/CIRCULATIONAHA.123.065330

Hogan, Shea E., Eike Sebastian Debus, Mark R. Nehler, Manesh R. Patel, Sonia S. Anand, Eva Muehlhofer, Lloyd P. Haskell, Scott D. Berkowitz, Rupert M. Bauersachs, and Marc P. Bonaca. “Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD.” Circulation 149, no. 8 (February 20, 2024): 635–37. https://doi.org/10.1161/CIRCULATIONAHA.123.065330.

Hogan SE, Debus ES, Nehler MR, Patel MR, Anand SS, Muehlhofer E, et al. Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD. Circulation. 2024 Feb 20;149(8):635–7.

Hogan, Shea E., et al. “Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD.” Circulation, vol. 149, no. 8, Feb. 2024, pp. 635–37. Pubmed, doi:10.1161/CIRCULATIONAHA.123.065330.

Hogan SE, Debus ES, Nehler MR, Patel MR, Anand SS, Muehlhofer E, Haskell LP, Berkowitz SD, Bauersachs RM, Bonaca MP. Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD. Circulation. 2024 Feb 20;149(8):635–637.